Here’s what you should know.
1. Olympus will pay $34 million to its foreign investors and they will dismiss remaining claims against the company.
2. In 2012, Olympus allegedly made several irregular payments for its acquisitions that resulted in a significant asset impairment charges. False financial statements concealed approximately ¥376 billion yen , according to the New York Times.
3. The company will record the payment as a special loss for its third quarter. It expects no change to the full year group forecast.
More articles on gastroenterology/endoscopy:
GI leader to know: Dr. Henry Levine of the Center for Digestive Health
Welsh researchers make ‘breakthrough’ in diagnosing bowel cancer: 5 key notes
GI leader to know: Dr. Ivan Friedrich of The Gastroenterology Group of Northern New Jersey
